Agios Pharma Stock Performance
as on September 25, 2026 at 2:15 pm IST
Day's Low
Day's High
$31.37$34.12
4.65%
Downside
3.71%
Upside

52 Week's Low
52 Week's High
$22.24$46.00
32.40%
Downside
39.82%
Upside

Agios Pharma share price movements today
- Previous Close
- $34.19
- Open
- $34.00
- Volume
- 1.3M
- Market Cap
- $2.0B
- Day's Low - High
- $31.37 - $34.12
- 52 Week Low - High
- $22.24 - $46.00
Agios Pharma Historical Returns
- 1 Month Return
- -2.95 %
- 3 Month Return
- -9.12 %
- 1 Year Return
- -10.13 %
- 3 Year Return
- + 34.78 %
- 5 Year Return
- -30.77 %
Agios Pharma Stock Fundamentals & Key Indicators
Check Agios Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.0B
EPS (TTM)
-7.01
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.88
Industry PE ratio
-15.36
PEG Ratio
0.03050209030992801
EBITDA
-416.8M
Revenue (TTM)
98.3M
Profit Margin
87.92%
Return On Equity TTM
-35.67%
Agios Pharma Stock Valuation
Track how Agios Pharma P/E has moved over time to understand its valuation trends.
Agios Pharma in the last 5 years
Lowest (-6.64x)
December 31, 2022
Industry (-15.36x)
December 31, 2025
Today (-3.82x)
December 31, 2025
Highest (2.77x)
December 31, 2024
Today’s Price to Earnings Ratio: -3.82x
Agios Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Agios Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $2.0B | -30.77% | -4.88 | 87.92% | 0.00% | |
| Neutral | $72.7B | -54.71% | -22.82 | -12.57% | 0.00% | |
| StrongBuy | $130.9B | 184.51% | 29.81 | 86.04% | 0.00% | |
| Buy | $82.8B | 24.59% | 19.15 | 84.86% | 0.46% |
Stock Returns calculator for Agios Pharma Stock including INR - Dollar returns
The Agios Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Agios Pharma investment value today
Current value as on today
₹97,122
Returns
Returns from Agios Pharma Stock
Dollar Impact
₹7,256 (+7.26%)
Analyst Recommendation on Agios Pharma Stock
Based on 4 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Agios Pharma. Average target price of $46.25
Agios Pharma Share Price Target
Get share price movements and forecasts by analysts on Agios Pharma.
What analysts predicted
28.86%UPSIDE
Target Price
$46.25
Current Price
$32.9
Analyzed by
4 Analysts
Target
$46.25
Agios Pharma target price $46.25, a slight upside of 28.86% compared to current price of $32.9. According to 4 analysts rating.
Indian Investors' Interest in Agios Pharma Stock
Search interest for Agios Pharma Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
Agios Pharma Quarterly Profit & Loss
All numbers in Millions USD
Agios Pharma Annual Profit & Loss
All numbers in Millions USD
Agios Pharma Quarterly Cash Flow
All numbers in Millions USD
Agios Pharma Annual Cash Flow
All numbers in Millions USD
Agios Pharma News & Key Events

Today's Timeline - 24 December
Wed, 10:37 AM
-Agios Pharmaceuticals announces FDA approval for AQVESME (mitapivat) for anemia in thalassemia, shares fell 1.4% to $24.59.
Wed, 06:01 PM
-Agios shares rise 9.80% to $27.00 premarket after FDA approval of AQVESME for thalassemia-related anemia.
Wed, 06:48 PM
-FDA expands approval for mitapivat, expected to generate $320 million additional peak revenue opportunity.

Today's Timeline - 24 December
Wed, 10:33 PM
-Management outlines marketing plans for AQVESME, targeting 4,000 patients with a price of $425,000 annually.
Insights on Agios Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 6 quarters, 8.72M → 44.74M (in $), with an average increase of 25.2% per quarter
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 701.7%
NO EFFECTAgainst Peers

In the last 3 years, Moderna, Inc. Common Stock has given 98.5% return, outperforming this stock by 63.7%
NEGATIVE IMPACTPrice Dip

In the last 1 month, AGIO stock has moved down by -2.9%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, -99.11M → -100.70M (in $), with an average decrease of 1.6% per quarter
About Agios Pharma
| Organisation | Agios Pharma |
| Headquarters | 88 Sidney Street, Cambridge, MA, 02139, US |
| Industry | Biotechnology |
| CEO | Brian Goff |
| E-voting on shares | Click here to vote |
Key Management of Agios Pharma
Name | Title |
|---|---|
Ms. Cecilia Jones | Chief Financial Officer |
Mr. James William Burns | Chief Legal Officer |
Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
Dr. Shin-San Su Ph.D. | Co-Founder |
Mr. Brian M. Goff M.B.A. | CEO & Director |
Dr. Krishnan Viswanadhan M.B.A., Pharm.D. | Chief Strategy & Operations Officer |
Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
Dr. Craig B. Thompson M.D. | Co-Founder |
Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
FAQs
What is Agios Pharma share price today?
Agios Pharma share price today is $32.90 as on at the close of the market. Agios Pharma share today touched a day high of $34.12 and a low of $31.37.
What is the 52 week high and 52 week low for Agios Pharma share?
Agios Pharma share touched a 52 week high of $46.00 on and a 52 week low of $22.24 on . Agios Pharma stock price today i.e. is closed at $32.90,which is 28.48% down from its 52 week high and 47.93% up from its 52 week low.
What is Agios Pharma's market capitalisation today?
Agios Pharma market capitalisation is $0.00T as on .
How to invest in Agios Pharma Stock (AGIO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Agios Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agios Pharma Shares that will get you 0.0456 shares as per Agios Pharma share price of $32.90 per share as on September 25, 2026 at 8:45 am IST.
What is the minimum amount required to buy Agios Pharma Stock (AGIO) from India?
Indian investors can start investing in Agios Pharma (AGIO) shares with as little as ₹95.945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.45 in Agios Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Agios Pharma share’s latest price of $32.90 as on September 25, 2026 at 8:45 am IST, you will get 0.3040 shares of Agios Pharma. Learn more about
fractional shares .
What are the returns that Agios Pharma has given to Indian investors in the last 5 years?
Agios Pharma stock has given -30.77% share price returns and 29.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?